U.S. President Donald Trump has issued an executive order to reduce the number of childhood vaccinations by streamlining the inoculation schedule to include 11 immunizations. Trump mentioned that this approach would offer U.S. children top-tier protection and bring the country in line with other nations recommending fewer shots. The order reflects a key objective of Health Secretary Robert F. Kennedy Jr., who is known for his anti-vaccine stance and claims linking vaccines to autism, despite scientific evidence refuting these claims.
The executive order suggests dividing the childhood MMR (measles, mumps, and rubella) vaccine into three shots and administering them separately during medical visits. Earlier, Kennedy had trimmed the U.S. immunization schedule by eliminating shots for six out of 17 diseases, a decision that was temporarily blocked by a federal court ruling. The latest order specifies that the federal government will only endorse the remaining 11 vaccinations.
While the order proposes revised vaccine recommendations, it is clarified that states, not the federal government, possess the authority to mandate vaccinations for schoolchildren. States with existing school vaccine requirements are encouraged to contemplate updating their laws to align with the administration’s preferred schedule, according to a White House briefing.
Republican Oklahoma Governor Kevin Stitt commended the order for enhancing clarity and transparency in vaccine recommendations. However, Democratic Governors J.B. Pritzker of Illinois and Josh Shapiro of Pennsylvania criticized the directive, citing concerns about the spread of misinformation amid rising measles cases in the country.
The order also tasks the Justice Department with challenging state vaccination laws, directing the attorney general to litigate against state regulations that conflict with parental rights, religious freedoms, disability accommodations, and equal protection, including provisions on religious and medical exemptions from immunization mandates.
Medical associations, public health experts, and vaccine manufacturers have voiced opposition to the order. Dr. Aaron Milstone of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases highlighted the potential for parental confusion due to conflicting messages, which might result in delayed vaccination schedules. Merck, a vaccine manufacturer, emphasized that there is no scientific evidence supporting the benefits of splitting the MMR combination shot into three components, warning that this approach could lead to missed or delayed immunizations.
Dr. Elizabeth Mack, a pediatric critical care physician, raised concerns about the feasibility of the recommendation due to the absence of licensed single-antigen measles, mumps, or rubella vaccines in the U.S., questioning logistical challenges for parents and reimbursement for additional medical visits. Pharmaceutical lobby group PhRMA’s Chief Medical Officer Mike Ybarra stressed the importance of evidence-based decision-making in modifying vaccination schedules.
Despite the support from some officials, such as Oklahoma Governor Stitt, the order has faced significant backlash from healthcare experts and lawmakers, including Republican Senator Bill Cassidy, who denounced the directive as misguided and criticized the President’s authority in making such changes.
The World Health Organization defended the scientific basis behind childhood immunization schedules, emphasizing the extensive research and expert evaluations that inform vaccination recommendations globally. Trump, Kennedy, and other White House officials highlighted that under the new schedule, U.S. children would receive notably fewer injections compared to the previous guideline of 72 shots, a figure that experts argue is inflated due to counting combination shots as multiple injections.
In conclusion, the executive order’s implications have sparked a contentious debate among healthcare professionals, policymakers, and experts, underscoring the complex considerations surrounding childhood vaccinations and the need for evidence-based decision-making in public health policies.